Buscar
Mostrando ítems 51-60 de 3191
Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD
(Nature Publishing Group, 2012-12-01)
Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD
(Nature Publishing Group, 2012-12-01)
Improvement of Disability in Ulcerative Colitis Patients Aft er One Year With Anti-TNF Agents
(Nature Publishing Group, 2018-02-01)
Predictors of Health-Related Quality of Life in Patients with Inflammatory Bowel Disease After 1 Year with Anti-TNF Agents
(Lippincott Williams & Wilkins, 2016-03-01)
Improvement of Anxiety and Depression Rates After 1 Year Treatment with Anti-TNF Agents in Patients with Inflammatory Bowel Disease
(Lippincott Williams & Wilkins, 2016-03-01)
Improvement of Disability in Ulcerative Colitis Patients After One Year With Anti-TNF Agents
(Lippincott Williams & Wilkins, 2018-02-01)
The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism
(Springer, 2011)
The introduction of antitumor necrosis factor
(TNF) agents has improved the outcome for many patients
with rheumatoid arthritis (RA). To date, the only replicated
genetic predictor of anti-TNF response is the −308 G > ...